about
Leveraging Social Networking Sites for an Autoimmune Hepatitis Genetic Repository: Pilot Study to Evaluate Feasibility.Targeting incretin hormones and the ASK-1 pathway as therapeutic options in the treatment of non-alcoholic steatohepatitis.Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease.Extrahepatic Autoimmune Diseases are Prevalent in Autoimmune Hepatitis Patients and Their First-Degree Relatives: Survey StudyRandomized Controlled Trial of a Leucine-Metformin-Sildenafil Combination (NS-0200) on Weight and Metabolic ParametersRelationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trialSevere and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factorsCharacteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study
P50
Q47557422-D32770FB-F106-4FD4-A373-8C42146C3CA3Q52337360-1F50950E-3052-4EF2-AE50-1BFDDB9ECF7CQ54528195-CE324F43-1733-4155-95D3-49257F9FF655Q60947949-DC6A456B-EB04-4EDF-8CFC-7D18C1ED9CBEQ90657720-455B75D3-FC7E-4CF0-AA0D-4EC19BF57110Q92259912-D5C7638A-FE59-4220-9B05-75D4DBAD6B48Q92751825-D010B1C8-F40E-4301-86A2-333FF9E6DA03Q93049862-36F90E8E-090F-4E65-BBD6-A99387D91529
P50
description
researcher
@en
name
Naga Chalasani
@en
type
label
Naga Chalasani
@en
prefLabel
Naga Chalasani
@en
P31
P496
0000-0003-4082-3178